BR9711812A - EsterÄides como estimuladores neuroqu¡micos do ÄrgÆo vomeronasal para aliviar os sintomas de pms e ansiedade - Google Patents
EsterÄides como estimuladores neuroqu¡micos do ÄrgÆo vomeronasal para aliviar os sintomas de pms e ansiedadeInfo
- Publication number
- BR9711812A BR9711812A BR9711812A BR9711812A BR9711812A BR 9711812 A BR9711812 A BR 9711812A BR 9711812 A BR9711812 A BR 9711812A BR 9711812 A BR9711812 A BR 9711812A BR 9711812 A BR9711812 A BR 9711812A
- Authority
- BR
- Brazil
- Prior art keywords
- pms
- steroids
- anxiety
- relieve symptoms
- vomeronasal organ
- Prior art date
Links
- 150000003431 steroids Chemical class 0.000 title abstract 4
- 208000019901 Anxiety disease Diseases 0.000 title abstract 2
- 230000036506 anxiety Effects 0.000 title abstract 2
- 208000024891 symptom Diseases 0.000 title abstract 2
- 230000001722 neurochemical effect Effects 0.000 title 1
- 210000001121 vomeronasal organ Anatomy 0.000 title 1
- 206010036618 Premenstrual syndrome Diseases 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/002—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 13 (17)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/686,092 US6057439A (en) | 1994-08-04 | 1996-07-23 | Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety |
| US72586296A | 1996-10-04 | 1996-10-04 | |
| PCT/US1997/013035 WO1998003207A1 (en) | 1996-07-23 | 1997-07-23 | Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9711812A true BR9711812A (pt) | 1999-08-24 |
Family
ID=27103741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9711812A BR9711812A (pt) | 1996-07-23 | 1997-07-23 | EsterÄides como estimuladores neuroqu¡micos do ÄrgÆo vomeronasal para aliviar os sintomas de pms e ansiedade |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0914165B1 (pt) |
| JP (1) | JP4450435B2 (pt) |
| KR (1) | KR20000067970A (pt) |
| CN (1) | CN1226837A (pt) |
| AT (1) | ATE342721T1 (pt) |
| AU (1) | AU726625B2 (pt) |
| BG (1) | BG103115A (pt) |
| BR (1) | BR9711812A (pt) |
| CA (1) | CA2260253A1 (pt) |
| DE (1) | DE69736833T2 (pt) |
| ES (1) | ES2273374T3 (pt) |
| NO (1) | NO990305L (pt) |
| NZ (1) | NZ333671A (pt) |
| PL (1) | PL331357A1 (pt) |
| WO (1) | WO1998003207A1 (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5922699A (en) * | 1996-06-07 | 1999-07-13 | Pherin Corporation | 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function |
| FR2791572A1 (fr) * | 1999-03-31 | 2000-10-06 | Adir | Utilisation d'hormones sexuelles pour l'obtention d'une composition pharmaceutique nasale utile pour le traitement des saignements uterins indesirables |
| CA2325106A1 (en) * | 1999-12-06 | 2001-06-06 | Stanley L. Gore | Compositions and methods for intranasal delivery of active agents to the brain |
| US6555531B1 (en) * | 1999-12-30 | 2003-04-29 | Pherin Pharmaceuticals, Inc. | Weight promoting composition, method, and product |
| US8309539B2 (en) | 2005-09-09 | 2012-11-13 | Pherin Pharmaceuticals, Inc. | Acute treatment of social phobia |
| EP2278880B1 (en) * | 2008-04-09 | 2012-10-10 | Pherin Pharmaceuticals, Inc. | Steroid treatment for hot flashes |
| ES2625778T3 (es) * | 2012-12-28 | 2017-07-20 | Pherin Pharmaceuticals, Inc. | Uso de pregn-4-en-20-in-3-ona para el tratamiento de trastornos depresivos |
| ES2972282T3 (es) * | 2019-04-15 | 2024-06-12 | Vistagen Therapeutics Inc | Tratamiento de la migraña |
| WO2021080880A1 (en) * | 2019-10-25 | 2021-04-29 | Covey Douglas | Nmdar inhibiting agents and gabaar potentiating agents and uses thereof |
| CN112608358A (zh) * | 2020-12-29 | 2021-04-06 | 北京大学 | 一种促进花粉萌发的化合物及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5208227A (en) * | 1987-08-25 | 1993-05-04 | University Of Southern California | Method, compositions, and compounds for modulating brain excitability |
| US5969168A (en) * | 1991-01-07 | 1999-10-19 | Pherin Corporation | Androstanes for inducing hypothalamic effects |
| EP1340502A3 (en) * | 1993-06-15 | 2004-01-21 | Pherin Corporation | Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| RO117454B1 (ro) * | 1993-06-15 | 2002-03-29 | Pherin Corp Menlo Park | Derivati de steroizi estrenici, compozitie care ii contine si metoda de tratament |
| US5792757A (en) * | 1994-08-04 | 1998-08-11 | Pherin Pharmaceuticals | 19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function |
| US5563131A (en) * | 1994-08-04 | 1996-10-08 | Pherin Corporation | Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| MX9702253A (es) * | 1994-09-29 | 1997-06-28 | Pherin Corp | Nuevos estrenos para inducir efectos hipotalamicos |
| US5922699A (en) * | 1996-06-07 | 1999-07-13 | Pherin Corporation | 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function |
-
1997
- 1997-07-23 JP JP50723098A patent/JP4450435B2/ja not_active Expired - Fee Related
- 1997-07-23 EP EP97937019A patent/EP0914165B1/en not_active Expired - Lifetime
- 1997-07-23 PL PL97331357A patent/PL331357A1/xx unknown
- 1997-07-23 AT AT97937019T patent/ATE342721T1/de not_active IP Right Cessation
- 1997-07-23 DE DE69736833T patent/DE69736833T2/de not_active Expired - Lifetime
- 1997-07-23 CA CA002260253A patent/CA2260253A1/en not_active Abandoned
- 1997-07-23 AU AU39637/97A patent/AU726625B2/en not_active Ceased
- 1997-07-23 CN CN97196761A patent/CN1226837A/zh active Pending
- 1997-07-23 BR BR9711812A patent/BR9711812A/pt not_active IP Right Cessation
- 1997-07-23 KR KR1019997000478A patent/KR20000067970A/ko not_active Withdrawn
- 1997-07-23 WO PCT/US1997/013035 patent/WO1998003207A1/en not_active Ceased
- 1997-07-23 ES ES97937019T patent/ES2273374T3/es not_active Expired - Lifetime
- 1997-07-23 NZ NZ333671A patent/NZ333671A/xx unknown
-
1999
- 1999-01-22 NO NO990305A patent/NO990305L/no not_active Application Discontinuation
- 1999-01-25 BG BG103115A patent/BG103115A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP4450435B2 (ja) | 2010-04-14 |
| NO990305D0 (no) | 1999-01-22 |
| CN1226837A (zh) | 1999-08-25 |
| EP0914165A4 (en) | 2004-01-21 |
| JP2000513000A (ja) | 2000-10-03 |
| NO990305L (no) | 1999-03-22 |
| AU726625B2 (en) | 2000-11-16 |
| ATE342721T1 (de) | 2006-11-15 |
| EP0914165B1 (en) | 2006-10-18 |
| DE69736833T2 (de) | 2007-05-24 |
| NZ333671A (en) | 2000-07-28 |
| KR20000067970A (ko) | 2000-11-25 |
| AU3963797A (en) | 1998-02-10 |
| CA2260253A1 (en) | 1998-01-29 |
| BG103115A (en) | 1999-09-30 |
| DE69736833D1 (de) | 2006-11-30 |
| PL331357A1 (en) | 1999-07-05 |
| ES2273374T3 (es) | 2007-05-01 |
| EP0914165A1 (en) | 1999-05-12 |
| WO1998003207A1 (en) | 1998-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ312303A (en) | Novel nor-pregnanes for inducing hypothalamic effects | |
| NO985975L (no) | Blandinger og fremgangsmÕter for frembringelse av farmakologisk aktive preparater og anvendelser derav | |
| HUT77966A (hu) | II.Típusú ösztrogénreceptor antagonista hatású flavanolignánokat tartalmazó antiproliferatív hatású gyógyszerkészítmények és azok előállítása | |
| MD1920F2 (ro) | Compoziţie şi metodă de profilaxie sau frânare a debutului bolii Alzheimer | |
| MY131522A (en) | PHARMACEUTICAL COMPOSITION AND USES FOR ANDROST-5-ENE-3ß,17ß-DIOL | |
| BR9711812A (pt) | EsterÄides como estimuladores neuroqu¡micos do ÄrgÆo vomeronasal para aliviar os sintomas de pms e ansiedade | |
| CA2440605A1 (en) | Methods for treating stress disorders using glucocorticoid receptor-specific antagonists | |
| BR9307867A (pt) | Esteroides de androstano como iniciadores neuroquimicos de alteraçao na funçao hipotalamica humana e composiçoes e métodos farmaceuticos relacionados | |
| BR0008076A (pt) | 16-hidroxiestratrienos como estrogênios de efeito seletivo | |
| CA2258177A1 (en) | 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function | |
| FI956028A0 (fi) | Estreenisteroidit ihmisen hypotalaamisen toiminnan muuttamisen neurokemiallisina initiaattoreina sekä tähän liittyvät farmaseuttiset koostumukset ja menetelmät | |
| RU2004116082A (ru) | Применение (11бета, 17 бета)-11-(1,3-бензодиоксол-5-ил)-17-гидрокси-17-(1-пропинил) эстра-4,9-диен-3-она при лечении большого депрессивного расстройства | |
| DE69525181D1 (de) | Tnf-rezeptor und steroidhormon dhea in einer kombinationstherapie | |
| CA2196690A1 (en) | Pregnanes and cholanes as neurochemical initiators of change in hypothalamic function | |
| BR9816142A (pt) | Esteróides de 19-nor-colano como iniciadores neuroquìmicos de mudança na função hipotalâmica humana | |
| MXPA94000705A (es) | Esteroides de estreno como iniciadores neuroquimicos del cambio en la funcion hipotalamica humana ycomposiciones farmaceuticas y metodos relacionados. | |
| TW289730B (en) | Pharmaceutical composition for alleviating the symptoms of psychoses, depression or anxiety comprising androstene steroids | |
| ATE318612T1 (de) | Methoden und zusammensetzungen zur behandlung der hyperlipidämie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A,7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1833 DE 21/02/2006. |